Spectradyne is a Launching an exciting new product for analysis of biological nanoparticles including extracellular vesicles (EVs), virus, LNPs and vectors for gene therapy.
Join the LIVE virtual launch event to learn more, on Thursday, September 8, 2022 starting at 11am Eastern Time.
Spectradyne’s CEO, Dr. Jean-Luc Fraikin will introduce the new technology and host a discussion panel featuring key opinion leaders from the field.
Register now for this Exciting Launch Event on September 8, 2022!
Find other particle analysis resources at: